story of the week
Sotorasib Plus Panitumumab for Refractory Colorectal Cancer With Mutated KRAS G12C
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
N. Engl. J. Med 2023 Oct 22;[EPub Ahead of Print], MG Fakih, L Salvatore, T Esaki, DP Modest, DP Lopez-Bravo, J Taieb, MV Karamouzis, E Ruiz-Garcia, TW Kim, Y Kuboki, F Meriggi, D Cunningham, KH Yeh, E Chan, J Chao, Y Saportas, Q Tran, C Cremolini, F PietrantonioFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.